In case you missed it: April 5 to April 9
It was a very busy week for the Contemporary OB/GYN® team.
This week’s top articles included:
Hormone therapy for postmenopausal women with nocturia
A prospective observational study found that hormone therapy resulted in a significant reduction in nocturia prevalence and bother in postmenopausal women with two nocturnal voids.
Oral contraceptive and ovarian function
A prospective study to assess the effects of an oral contraceptive containing estetrol and drospirenone on ovarian function found treatment achieved complete ovulation inhibition.
Current Management of Uterine Fibroids
Two experts discuss the goals of treatment and the expanding therapeutic landscape. This article was sponsored by Myovant Sciences.
Reduced Testing, Higher Positivity Rates for Prescription and Illegal Drugs During the COVID-19 Pandemic in 2020
Lower levels of testing and higher positivity rates, higher rates of dangerous drug combination use, and increases in fatal and non-fatal overdoses during the coronavirus disease 2019 (COVID-19) pandemic reveal a need for more resources to address the opioid epidemic in the United States.
Evaluation & Management of COVID-19 in Pregnancy
Treating COVID-19 in pregnant patients brings extra challenges, risks.
Gender discrepancy found in ABCA4-associated retinopathy
April 18th 2024A recent meta-analysis suggests sex as a modifying factor in the development of ABCA4-associated retinopathy, revealing a higher proportion of women among individuals with a mild reduced penetrant ABCA4 variant, impacting prognosis predictions and recurrence risks.
Read More
